This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
5 Growth Stocks in MedTech Set to Scale Higher in 2018
by Zacks Equity Research
The U.S. MedTech markets have been riding high with merger and acquisitions in focus.
Here Comes the CPI: Global Week Ahead
by John Blank
U.S. consumer price data for February will be closely watched on Tuesday.
Zacks.com featured highlights include: ePlus, HCA, US Foods, Best Buy and Ruth???s
by Zacks Equity Research
Zacks.com featured highlights include: ePlus, HCA, US Foods, Best Buy and Ruth???s
Invest in These 5 Stocks Powered by Relative Price Strength
by Nilanjan Choudhury
Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.
Tenet Healthcare (THC) Surges: Stock Moves 8.9% Higher
by Zacks Equity Research
Shares of Tenet Healthcare (THC) rose 9% yesterday after the company reported better-than-expected fourth-quarter results.
Zacks.com highlights: Sally Beauty Holdings, HCA Healthcare, MEDNAX, Cimpress N.V. and FTI Consulting
by Zacks Equity Research
Zacks.com highlights: Sally Beauty Holdings, HCA Healthcare, MEDNAX, Cimpress N.V. and FTI Consulting
Forget Market Volatility With These 5 Low-Beta Stocks
by Zacks Equity Research
We have figured out a proven strategy that says lucrative returns can also be earned from less-risky stocks if some other parameters are considered.
Acadia Healthcare (ACHC) Beats on Q4 Earnings, Revenues
by Zacks Equity Research
Acadia Healthcare's (ACHC) fourth-quarter 2017 results gained on higher contribution from its facilities in the U.K. and the United States.
Acadia Healthcare (ACHC) Beats on Earnings & Revenues in Q4
by Zacks Equity Research
Acadia Healthcare's (ACHC) fourth-quarter 2017 results gained on higher contribution from its facilities in the U.K. and the United States.
The Zacks Analyst Blog Highlights: Boeing, PetMed, Micron, Healthcare and RH
by Tirthankar Chakraborty
The Zacks Analyst Blog Highlights: Boeing, PetMed, Micron, Healthcare and RH
Inflation Scares Overblown! Grab 5 Growth Stocks Now
by Tirthankar Chakraborty
The rise in consumer price index (CPI), especially on a year-on-year basis, remained sluggish, while the recent wage growth was primarily due to seasonal factors that are not likely to last long.
Top Ranked Growth Stocks to Buy for February 15th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, February 15th:
CVS Health (CVS) Plans to Boost Hourly Minimum Wage Rate
by Zacks Equity Research
CVS Health (CVS) raises minimum wage level on benefits earned from tax savings. The company plans to put the remaining savings back into the business.
Zacks.com highlights: HCA Healthcare, Cimpress N.V. and Virtu Financial
by Zacks Equity Research
Zacks.com highlights: HCA Healthcare, Cimpress N.V. and Virtu Financial
Top Ranked Growth Stocks to Buy for February 12th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, February 12th
AmerisourceBergen (ABC) Gains on World Courier Unit Strength
by Zacks Equity Research
AmerisourceBergen's (ABC) World Courier business gets GDP designation.
3 Low-Beta Stocks to Ease Jitters From Market Volatility
by Zacks Equity Research
Our intense research has developed a strategy that allows investors to spend money on securities with lower risk and fetch attractive returns.
Top Ranked Growth Stocks to Buy for February 9th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, February 9th:
Top Ranked Growth Stocks to Buy for February 9th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, February 9th:
New Strong Buy Stocks for February 6th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
HCA Healthcare (HCA) Q4 Earnings Miss Estimates
by Zacks Equity Research
HCA Healthcare came out with adjusted earnings per share of $1.30, that missed the Zacks Consensus Estimate of $1.86.
HCA Healthcare (HCA) Surges: Stock Moves 6.1% Higher
by Zacks Equity Research
HCA Healthcare (HCA) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
HCA Healthcare (HCA) Q3 Earnings, Revenues Meet Estimates
by Zacks Equity Research
HCA Healthcare's (HCA) third quarter earnings reflect improvement in revenues offset by increase in expenses.
AET, EVHC, HCA Q3 Earnings: Here are the Key Predictions
by Zacks Equity Research
Third-quarter results of the Healthcare stocks are likely to be impacted by the noise around Affordable Care Act, industry-wide softness in volume, rising level of bad debt and higher expenses.
Will Higher Admissions Aid HCA Healthcare (HCA) Q3 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) third-quarter earnings are likely to be benefited by its inorganic growth measures partly offset by industry weakness.